Literature DB >> 18811115

Photorefractive keratectomy retreatment after LASIK.

Waldir Neira-Zalentein1, Jukka A O Moilanen, Ilpo S Tuisku, Juha M Holopainen, Timo M T Tervo.   

Abstract

PURPOSE: To study the results of late photorefractive keratectomy (PRK) in corneas originally subjected to LASIK.
METHODS: Seven eyes of seven patients who had LASIK for myopia were retreated with PRK at least 2 years after LASIK. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), refraction, and haze were evaluated before and after LASIK and after retreatment by PRK.
RESULTS: Photorefractive keratectomy retreatment improved BSCVA in six (86%) of seven eyes, and one (14%) eye showed no changes. None of the eyes lost lines of BSCVA. Five of seven eyes developed mild haze, which disappeared before the last postoperative follow-up.
CONCLUSIONS: Photorefractive keratectomy retreatment performed at least 2 years after LASIK can improve visual acuity. We hypothesize that LASIK-induced corneal nerve damage disturbs corneal wound healing by increasing the tendency for development of haze.

Entities:  

Mesh:

Year:  2008        PMID: 18811115     DOI: 10.3928/1081597X-20080901-12

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  3 in total

Review 1.  Corneal Regeneration After Photorefractive Keratectomy: A Review.

Authors:  Javier Tomás-Juan; Ane Murueta-Goyena Larrañaga; Ludger Hanneken
Journal:  J Optom       Date:  2014-10-23

2.  Results of laser enhancement for residual myopia after primary laser in situ keratomileusis.

Authors:  Mahfouth A Bamashmus; Hisham A Al-Akhlee; Yasmin A Al-Azani; Najeeb A Al-Kershy
Journal:  Taiwan J Ophthalmol       Date:  2019-11-07

3.  Photorefractive Keratectomy with Adjunctive Mitomycin C for Residual Error after Laser-Assisted In Situ Keratomileusis Using the Pulzar 213 nm Solid-State Laser: Early Results.

Authors:  Maya Fe Ng-Darjuan; Raymond P Evangelista; Archimedes Lee D Agahan
Journal:  ISRN Ophthalmol       Date:  2013-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.